These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1161966)
1. Urinary excretion of the sulphate and glucuronide of 3-methoxy-4-hydroxyphenylethyleneglycol in a manic-depressive patient. Bond PA; Dimitrakoudi M; Howlett DR; Jenner FA Psychol Med; 1975 Aug; 5(3):279-85. PubMed ID: 1161966 [TBL] [Abstract][Full Text] [Related]
2. Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients. Joseph MH; Baker HF; Johnstone EC; Crow TJ Psychopharmacology (Berl); 1976 Dec; 51(1):47-51. PubMed ID: 827775 [TBL] [Abstract][Full Text] [Related]
3. Circadian course of body temperature and the excretion of MHPG and VMA in a patient with bipolar depression. Pflug B; Engelmann W; Gaertner HJ J Neural Transm; 1982; 53(2-3):213-5. PubMed ID: 7077317 [TBL] [Abstract][Full Text] [Related]
4. Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG. Blombery PA; Kopin IJ; Gordon EK; Markey SP; Ebert MH Arch Gen Psychiatry; 1980 Oct; 37(10):1095-8. PubMed ID: 7425794 [TBL] [Abstract][Full Text] [Related]
5. [Urinary excretion of vanilmandelic acid in various clinical phases of manic-depressive psychosis]. Catalano A; Campanini T; De Risio C Riv Sper Freniatr Med Leg Alien Ment; 1971 Apr; 95(2):392-400. PubMed ID: 5091478 [No Abstract] [Full Text] [Related]
6. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Greenspan K; Schildkraut JJ; Gordon EK; Levy B; Durell J Arch Gen Psychiatry; 1969 Dec; 21(6):710-6. PubMed ID: 4901154 [No Abstract] [Full Text] [Related]
7. Dopamine excretion in affective states and following Li2Co3 therapy. Messiha FS; Agallianos D; Clower C Nature; 1970 Feb; 225(5235):868-9. PubMed ID: 5415120 [No Abstract] [Full Text] [Related]
8. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878 [TBL] [Abstract][Full Text] [Related]
9. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Schildkraut JJ; Orsulak PJ; LaBrie RA; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA Arch Gen Psychiatry; 1978 Dec; 35(12):1436-9. PubMed ID: 727879 [TBL] [Abstract][Full Text] [Related]
10. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ Am J Psychiatry; 1982 Apr; 139(4):471-5. PubMed ID: 7065292 [TBL] [Abstract][Full Text] [Related]
11. Determination of 4-O-methylated catecholamine metabolites in urine by mass fragmentography. Muskiet FA; Fremouw-Ottevangers DC; Nagel GT; Wolthers BG Clin Chem; 1979 Oct; 25(10):1708-13. PubMed ID: 476919 [TBL] [Abstract][Full Text] [Related]
12. Urinary catecholamine metabolites during behavioral changes in a patient with manic-depressive cycles. Jones FD; Maas JW; Dekirmenjian H; Fawcett JA Science; 1973 Jan; 179(4070):300-2. PubMed ID: 4683130 [TBL] [Abstract][Full Text] [Related]
13. Psychiatric and biochemical profiles of lithium therapy in mania. (Case report). Savage C; Messiha FS Dis Nerv Syst; 1972 Jun; 33(6):409-12. PubMed ID: 4668961 [No Abstract] [Full Text] [Related]
14. Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects. Wehr TA; Muscettola G; Goodwin FK Arch Gen Psychiatry; 1980 Mar; 37(3):257-63. PubMed ID: 7362415 [TBL] [Abstract][Full Text] [Related]
15. Manifest psychopathology and urine biochemical measures. Multivariate analyses in manic-depressive illness. Rubin RT; Overall JE Arch Gen Psychiatry; 1970 Jan; 22(1):45-57. PubMed ID: 5409520 [No Abstract] [Full Text] [Related]
16. Urinary cyclic AMP in relation to lithium treatment in manic-depressive illness. Sen AK; Awad AG; Stancer HC; Godse DD J Nerv Ment Dis; 1976 Sep; 163(3):210-3. PubMed ID: 182919 [TBL] [Abstract][Full Text] [Related]
17. MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep. Schildkraut JJ; Keeler BA; Papousek M; Hartmann E Science; 1973 Aug; 181(4101):762-4. PubMed ID: 4353428 [TBL] [Abstract][Full Text] [Related]
18. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Swann AC; Koslow SH; Katz MM; Maas JW; Javaid J; Secunda SK; Robins E Arch Gen Psychiatry; 1987 Apr; 44(4):345-54. PubMed ID: 2436590 [TBL] [Abstract][Full Text] [Related]
19. Gas-chromatographic estimation of urinary vanilmandelic acid (VMA) and 3-methoxy-4-hydroxyphenylethylenglycol (MHPG) after their purification on Sephadex LH-20. Cagnasso M; Biondi PA Ital J Biochem; 1974; 23(5):345-55. PubMed ID: 4452624 [No Abstract] [Full Text] [Related]
20. The urinary excretion of 3-methoxy-4-hydroxyphenylglycól in acute myocardial infarction. Wocial B; Sznajderman M; Januszewicz W; Raczyński J Clin Chim Acta; 1979 Aug; 95(3):517-20. PubMed ID: 487590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]